Total Valuation
ilShinbiobase Co., Ltd. has a market cap or net worth of ₩43.05B. The enterprise value is -₩5.41K.
Market Cap₩43.05B
Enterprise Value-₩5.41K
Share Statistics
ilShinbiobase Co., Ltd. has 44,216,140 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding44,216,140
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
ilShinbiobase Co., Ltd.’s return on equity (ROE) is 0.07 and return on invested capital (ROIC) is 5.74%.
Return on Equity (ROE)0.07
Return on Assets (ROA)0.07
Return on Invested Capital (ROIC)5.74%
Return on Capital Employed (ROCE)0.07
Revenue Per Employee10.00T>
Profits Per Employee10.00T>
Employee Count―
Asset Turnover0.21
Inventory Turnover0.76
Valuation Ratios
The current PE Ratio of ilShinbiobase Co., Ltd. is 10.2. ilShinbiobase Co., Ltd.’s PEG ratio is 0.67.
PE Ratio10.2
PS Ratio4.96
PB Ratio1.11
Price to Fair Value1.11
Price to FCF13.71
Price to Operating Cash Flow6.05
PEG Ratio0.67
Income Statement
In the last 12 months, ilShinbiobase Co., Ltd. had revenue of 14.53B and earned 4.79B in profits. Earnings per share was 115.01.
Revenue14.53B
Gross Profit7.59B
Operating Income4.56B
Pretax Income5.86B
Net Income4.79B
EBITDA4.98B
Earnings Per Share (EPS)115.01
Cash Flow
In the last 12 months, operating cash flow was 8.65B and capital expenditures 2.40M, giving a free cash flow of 8.66B billion.
Operating Cash Flow8.65B
Free Cash Flow8.66B
Free Cash Flow per Share195.95
Dividends & Yields
ilShinbiobase Co., Ltd. pays an annual dividend of ₩10, resulting in a dividend yield of ―
Dividend Per Share₩10
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.30
52-Week Price Change-33.70%
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)101.17K
Important Dates
ilShinbiobase Co., Ltd. upcoming earnings date is Nov 12, 2026, TBA (Confirmed).
Last Earnings DateAug 18, 2026
Next Earnings DateNov 12, 2026
Ex-Dividend Date―
Financial Position
ilShinbiobase Co., Ltd. as a current ratio of 14.82, with Debt / Equity ratio of 0.00%
Current Ratio14.82
Quick Ratio12.36
Debt to Market Cap0.00
Net Debt to EBITDA-0.40
Interest Coverage Ratio0.00
Taxes
In the past 12 months, ilShinbiobase Co., Ltd. has paid 1.07B in taxes.
Income Tax1.07B
Effective Tax Rate0.18
Enterprise Valuation
ilShinbiobase Co., Ltd. EV to EBITDA ratio is 14.08, with an EV/FCF ratio of 13.33.
EV to Sales4.83
EV to EBITDA14.08
EV to Free Cash Flow13.33
EV to Operating Cash Flow13.32
Balance Sheet
ilShinbiobase Co., Ltd. has ₩47.41B in cash and marketable securities with ₩0.00 in debt, giving a net cash position of ₩47.41B billion.
Cash & Marketable Securities₩47.41B
Total Debt₩0.00
Net Cash₩47.41B
Net Cash Per Share₩1.07K
Tangible Book Value Per Share₩1.51K
Margins
Gross margin is 51.79%, with operating margin of 31.37%, and net profit margin of 32.99%.
Gross Margin51.79%
Operating Margin31.37%
Pretax Margin40.36%
Net Profit Margin32.99%
EBITDA Margin34.27%
EBIT Margin31.37%
Analyst Forecast
The average price target for ilShinbiobase Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast32.31%
EPS Growth Forecast66.46%